Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics.
Páleníček T, Fujáková M, Brunovský M, Balíková M, Horáček J, Gorman I, Tylš F, Tišlerová B, Soš P, Bubeníková-Valešová V, Höschl C, Krajča V. Páleníček T, et al. Among authors: tyls f. Neuropsychobiology. 2011;63(4):202-18. doi: 10.1159/000321803. Epub 2011 Mar 22. Neuropsychobiology. 2011. PMID: 21422767
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.
Páleníček T, Fujáková M, Brunovský M, Horáček J, Gorman I, Balíková M, Rambousek L, Syslová K, Kačer P, Zach P, Bubeníková-Valešová V, Tylš F, Kubešová A, Puskarčíková J, Höschl C. Páleníček T, et al. Among authors: tyls f. Psychopharmacology (Berl). 2013 Jan;225(1):75-93. doi: 10.1007/s00213-012-2797-7. Epub 2012 Jul 29. Psychopharmacology (Berl). 2013. PMID: 22842791
The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis.
Fujáková M, Páleníček T, Brunovský M, Gorman I, Tylš F, Kubešová A, Řípová D, Krajča V, Horáček J. Fujáková M, et al. Among authors: tyls f. Pharmacol Biochem Behav. 2014 Jul;122:212-21. doi: 10.1016/j.pbb.2014.03.001. Epub 2014 Mar 11. Pharmacol Biochem Behav. 2014. PMID: 24631484
Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.
Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T. Bravermanová A, et al. Among authors: tyls f. Psychopharmacology (Berl). 2018 Feb;235(2):491-503. doi: 10.1007/s00213-017-4807-2. Epub 2018 Jan 5. Psychopharmacology (Berl). 2018. PMID: 29302713 Clinical Trial.
The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.
Dudysová D, Janků K, Šmotek M, Saifutdinova E, Kopřivová J, Bušková J, Mander BA, Brunovský M, Zach P, Korčák J, Andrashko V, Viktorinová M, Tylš F, Bravermanová A, Froese T, Páleníček T, Horáček J. Dudysová D, et al. Among authors: tyls f. Front Pharmacol. 2020 Dec 3;11:602590. doi: 10.3389/fphar.2020.602590. eCollection 2020. Front Pharmacol. 2020. PMID: 33343372 Free PMC article.
Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.
Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T. Viktorin V, et al. Among authors: tyls f. J Pers Med. 2022 Jun 19;12(6):1004. doi: 10.3390/jpm12061004. J Pers Med. 2022. PMID: 35743788 Free PMC article.
Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.
Nikolič M, Viktorin V, Zach P, Tylš F, Dudysová D, Janků K, Kopřivová J, Kuchař M, Brunovský M, Horáček J, Páleníček T. Nikolič M, et al. Among authors: tyls f. Eur Neuropsychopharmacol. 2023 Sep;74:78-88. doi: 10.1016/j.euroneuro.2023.04.019. Epub 2023 Jun 17. Eur Neuropsychopharmacol. 2023. PMID: 37336163 Clinical Trial.
19 results